Showing 881 - 900 results of 2,092 for search '"chemotherapy"', query time: 0.03s Refine Results
  1. 881

    Primary Lymphoma of the Liver: A Case Report and Review by Franzjosef Schweiger, Rowen Shinder, Sheldon Rubin

    Published 2000-01-01
    “…The response to treatment varies, but surgical resection and/or chemotherapy can result in prolonged remissions. The literature on this topic is briefly reviewed.…”
    Get full text
    Article
  2. 882

    Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax by Claudio Fozza

    Published 2024-01-01
    “…Secondary HLH typically occurs in conjunction with severe infections, malignancies or autoimmune disorders and intensive chemotherapy, potentially complicating treatment of acute myeloid leukemia (AML) in around 10% of cases. …”
    Get full text
    Article
  3. 883

    Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer by A.P.M. van der Meijden

    Published 2006-01-01
    “…The prognosis is determined by the likelihood of recurrence(30-70%) and/or progression to muscle invasive bladder cancer(1-15%).Trans urethral resection of bladder tumors remains the initial therapy but adjuvant intravesical instillations are necessary.All patients benefit from a single immediate post operative instillation with a chemotherapeutic agent and for low risk tumors this is the optimal therapy.Patients with intermediate and high risk tumors need more intravesical chemo-or immunotherapy. Chemotherapy reduces recurrences but not progression. …”
    Get full text
    Article
  4. 884

    Interactions between the tumor microbiota and breast cancer by Hua Guo

    Published 2025-01-01
    “…Gut microbes and their metabolites influence the development of breast cancer by regulating the tumor immune response, estrogen metabolism, chemotherapy, and immunotherapy effects. It was previously thought that there were no microorganisms in breast tissue, but it is now thought that there are microorganisms in breast cancer that can affect the outcome of the disease. …”
    Get full text
    Article
  5. 885

    Jejunal Perforation: A Rare Presentation of Burkitt’s Lymphoma—Successful Management by Samir Ranjan Nayak, Ganni Bhaskara Rao, Subramanya Sarma Yerraguntla, Sisir Bodepudi

    Published 2014-01-01
    “…We present an interesting case of jejunal perforation as a first manifestation of Burkitt’s lymphoma which was successfully managed with surgical resection, high dose chemotherapy, and good supportive care.…”
    Get full text
    Article
  6. 886
  7. 887

    Finite-difference and pseudo-spectral methodsfor the numerical simulations of in vitro human tumor cellpopulation kinetics by Z. Jackiewicz, B. Zubik-Kowal, B. Basse

    Published 2009-05-01
    “…Pseudo-spectral approximations areconstructed for the model equations describing the populationkinetics of human tumor cells in vitro and their responses toradiotherapy or chemotherapy. These approximations are moreefficient than finite-difference approximations. …”
    Get full text
    Article
  8. 888

    Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib by Maya Gross, Ryan J. Spencer

    Published 2022-01-01
    “…Current treatment options are limited; standards of care such as palliative chemotherapy and surgical resection often provide a small survival advantage. …”
    Get full text
    Article
  9. 889

    Gene Expression in Oligodendroglial Tumors by Elisabeth J. Shaw, Brian Haylock, David Husband, Daniel du Plessis, D. Ross Sibson, Peter C. Warnke, Carol Walker

    Published 2010-01-01
    “…Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity.…”
    Get full text
    Article
  10. 890

    Primary sclerosing encapsulating peritonitis by Swati Mishra, Kuldeep Chaudhary, Swati Tyagi, Pratibha Mishra, Vatsala Misra

    Published 2023-01-01
    “…It can be primary (idiopathic) or secondary (chemotherapy, beta-blockers, peritoneal dialysis, shunts, tuberculosis, systemic lupus erythematosus, etc.). …”
    Get full text
    Article
  11. 891

    A Fatal Case of Primary Basaloid Squamous Cell Carcinoma in the Intrahepatic Bile Ducts by Johan Kirkegaard, Mie Grunnet, Jane Preuss Hasselby

    Published 2014-01-01
    “…We describe a case of a 67-year-old man, who underwent chemotherapy and surgery for a right-sided liver tumor with an unusual presentation of metastasis to a lymph node in the left armpit. …”
    Get full text
    Article
  12. 892

    Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature by Mor Moskovitz, Mira Wollner, Nissim Haim

    Published 2015-01-01
    “…Oxaliplatin is a common chemotherapy drug, used mainly for colon and gastric cancer. …”
    Get full text
    Article
  13. 893

    A Rare Case of Renal Recovery in a Young Patient with Multiple Myeloma by Hasan J. Salameh, Adeel Ahmad, Tina Kochar

    Published 2013-01-01
    “…We describe an atypical presentation of MM in a young patient who presented with severe renal insufficiency requiring renal replacement therapy and achieved complete renal recovery with chemotherapy.…”
    Get full text
    Article
  14. 894

    Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity by Shanaz Khodaiji, Vidisha Mahajan, Krishna Sawaimoon Satyakam, Pratibha Sudhan Kadam Amare

    Published 2024-04-01
    “…This unusual case presentation is a challenge for the treating physician with the patient becoming resistant to chemotherapy and succumbing to the disease within a few months of diagnosis. …”
    Get full text
    Article
  15. 895

    Embryonal Sarcoma of the Liver in an Adult Patient by Nicole Lightfoot, Mehrdad Nikfarjam

    Published 2012-01-01
    “…She was tumour-free on imaging at 6 months without adjuvant chemotherapy. An UES should be considered in the differential of large cystic hepatic lesions, with aggressive surgical resection considered when possible.…”
    Get full text
    Article
  16. 896

    Malignant Fibrous Histiocytoma of the Kidney Treated with Nephrectomy and Adjuvant Radiotherapy: A Case Report by Rita Marchese, Pantaleo Bufo, Giuseppe Carrieri, Giuseppe Bove

    Published 2010-01-01
    “…Although radical nephrectomy is the most beneficial curative choice for this neoplasm, patients are often treated with adjuvant chemotherapy due to high risk of local recurrence and distant metastases. …”
    Get full text
    Article
  17. 897

    Subepithelial Corneal Deposits Associated with Exemestane by Annahita Amireskandari, Elena Nguyen, David Hinkle, Thomas Mauger

    Published 2020-01-01
    “…This is a case report of corneal deposits noted in a 69-year-old female patient taking the aromatase inhibitor, exemestane, after undergoing a mastectomy and chemotherapy for breast cancer. The patient presented to our eye clinic for a new-onset floater in one eye, and bilateral subepithelial opacities were found incidentally on exam. …”
    Get full text
    Article
  18. 898

    Survival from Primary Abdominal Lymphoma Presenting with a Mass and Obstructive Jaundice by Hugh J Freeman, Andrew M Seal

    Published 1996-01-01
    “…Pathological evaluation of the mass revealed a localized abdominal lymphoma. Treatment with chemotherapy and radiation resulted in complete clinical remission (for almost 14 years at the last evaluation). …”
    Get full text
    Article
  19. 899

    The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review by Brian H Dingle, R Bryan Rumble, Melissa C Brouwers

    Published 2005-01-01
    “…The treatment of choice is surgery, dependent on detection at a resectable stage. No chemotherapy or radiotherapy options have shown substantial activity. …”
    Get full text
    Article
  20. 900

    HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia by Mark R. Wallace

    Published 2020-01-01
    “…Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have emerged as a major complication of therapy. …”
    Get full text
    Article